Asklepios Klinik Harburg

Hamburg, Germany
Mental health clinic in Hamburg
Eißendorfer Pferdeweg 52, 21075 Hamburg

About Asklepios Klinik Harburg


"Bei Asklepios steht der Mensch im Mittelpunkt. Unsere Mitarbeiterinnen und Mitarbeiter behandeln in unseren Klinken und Lehrkrankenhäusern bundesweit pro Jahr mehr als zwei Millionen Patientinnen und Patienten auf höchstem medizinischen Niveau nach höchsten Qualitätsstandards. Dabei verfolgen wir stets den Anspruch, jeder Patientin und jedem Patienten eine bestmögliche Behandlung in einem jederzeit sicheren Umfeld bei gleichzeitig persönlicher Zuwendung zukommen zulassen. Ob Krankenhaus der Maximalversorgung, spezialisierte Fach- oder Rehaklinik, bei uns werden Sie von hochqualifizierten Fachkräften nach modernsten medizinischen Standards versorgt."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
Aeris Therapeutics
2
Boehringer Ingelheim
2
Morphotek
2
Abbott Medical Devices
1
Aktion Bronchialkarzinom e.V.
1
Alfacell
1
Charite University, Berlin, Germany
1
Corcym S.r.l
1
Daiichi Sankyo, Inc.
1
Hospital Universitario Getafe
1
Total Rows: 25

Clinical Trials at Asklepios Klinik Harburg


During the past decade, Asklepios Klinik Harburg conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 8 clinical trials were completed, i.e. on average, 53.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years3333332200222200000011223300Started TrialsCompleted Trails201520162017201820192020202101234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen
1997-05-01
Unknown status
300
Stalevo in Early Wearing-Off Patients
2005-08-01
2009-03-01
Completed
223
Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy With 5-Fluorouracil and Oxaliplatin Versus 5-Fluorouracil Alone in Rectal Cancer
2006-07-01
2016-06-01
Completed
1,256
A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors
2006-09-01
2014-06-01
Completed
1,252
Inoperable Non-Squamous NSCLC Stage III/IV: A Randomised Phase II Study With Bevacizumab Plus Erlotinib Or Gemcitabine/Cisplatin Plus Bevacizumab
2007-11-01
2012-05-01
Completed
224
Erlotinib Versus Carboplatin/Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
2006-06-01
Unknown status
260
An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma
2008-12-31
2014-01-10
Completed
89
Third International Study on Mechanical Ventilation
2010-04-01
2010-09-01
Completed
8,151

Rows per page:

1–31 of 31

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Asklepios Klinik Harburg" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Aeris Therapeutics" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Morphotek" with 2 trials sponsored and "Abbott Medical Devices" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 25 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Asklepios Klinik Harburg" #1 collaborator was "Abbott Medical Devices" with 1 trials as a collaborator, "Daiichi Sankyo Deutschland GmbH" with 1 trials as a collaborator, "FGK Clinical Research GmbH" with 1 trials as a collaborator, "Granzer Regulatory Consulting & Services" with 1 trials as a collaborator and "Heart Center Leipzig - University Hospital" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 4Hoffmann-La Roche: 4Aeris Therapeutics: 2Aeris Therapeutics: 2Boehringer Ingelheim: 2Boehringer Ingelheim: 2Morphotek: 2Morphotek: 2Abbott Medical Devices: 1Abbott Medical Devices: 1Aktion Bronchialkarzinom e.V.: 1Aktion Bronchialkarzinom e.V.: 1Alfacell: 1Alfacell: 1Charite University,Berlin, Germany: 1Charite University,Berlin, Germany: 1Corcym S.r.l: 1Corcym S.r.l: 1Daiichi Sankyo, Inc.: 1Daiichi Sankyo, Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsAbbott Medical Devices: 1Abbott Medical Devices: 1Daiichi SankyoDeutschland GmbH: 1Daiichi SankyoDeutschland GmbH: 1FGK Clinical Research GmbH: 1FGK Clinical Research GmbH: 1Granzer RegulatoryConsulting & Services:1Granzer RegulatoryConsulting & Services:1Heart Center Leipzig -University Hospital: 1Heart Center Leipzig -University Hospital: 1Revent Medical, Inc.: 1Revent Medical, Inc.: 1Roche Pharma AG: 1Roche Pharma AG: 1Syntactx: 1Syntactx: 1Ticeba GmbH: 1Ticeba GmbH: 1

Clinical Trials Conditions at Asklepios Klinik Harburg


According to Clinical.Site data, the most researched conditions in "Asklepios Klinik Harburg" are "Carcinoma, Non-Small-Cell Lung" (3 trials), "Aortic Valve Disease" (2 trials), "Non-Small Cell Lung Cancer" (2 trials), "Peripheral Arterial Disease" (2 trials) and "Pulmonary Emphysema" (2 trials). Many other conditions were trialed in "Asklepios Klinik Harburg" in a lesser frequency.

Clinical Trials Intervention Types at Asklepios Klinik Harburg


Most popular intervention types in "Asklepios Klinik Harburg" are "Drug" (16 trials), "Device" (9 trials), "Biological" (2 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (5 trials), "Cisplatin" (4 trials), "Pemetrexed" (4 trials), "Placebo" (4 trials) and "Erlotinib" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Asklepios Klinik Harburg


The vast majority of trials in "Asklepios Klinik Harburg" are 30 trials for "All" genders and 1 trials for "Male" genders.

Clinical Trials Status at Asklepios Klinik Harburg


Currently, there are NaN active trials in "Asklepios Klinik Harburg". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Asklepios Klinik Harburg, undefined suspended trials, and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Asklepios Klinik Harburg, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 9Phase 3: 9Not Applicable: 5Not Applicable: 5Phase 2: 5Phase 2: 5Phase 4: 2Phase 4: 2Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 15Completed: 15Terminated: 6Terminated: 6Active, not recruiting: 4Active, not recruiting: 4Unknown status: 4Unknown status: 4Recruiting: 2Recruiting: 2